+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Emphysema Treatment Market by Treatment Type (Pharmacological, Surgical), Drug Class (Anticholinergics, Beta-Agonists, Combination Drugs), Therapy Line, Route Of Administration, Dosage Form, Distribution Channel, Product Type - Global Forecast 2025-2030- Product Image
Emphysema Treatment Market by Treatment Type (Pharmacological, Surgical), Drug Class (Anticholinergics, Beta-Agonists, Combination Drugs), Therapy Line, Route Of Administration, Dosage Form, Distribution Channel, Product Type - Global Forecast 2025-2030- Product Image
Sale

Emphysema Treatment Market by Treatment Type (Pharmacological, Surgical), Drug Class (Anticholinergics, Beta-Agonists, Combination Drugs), Therapy Line, Route Of Administration, Dosage Form, Distribution Channel, Product Type - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 186 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6015346
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The emphysema treatment market is evolving rapidly as advancements in medical technology, new therapeutic pathways, and regulatory changes shape the future of chronic respiratory disease management for healthcare providers and industry leaders alike.

Market Snapshot: Emphysema Treatment Market Growth & Projections

The Emphysema Treatment Market grew from USD 6.83 billion in 2024 to USD 7.32 billion in 2025. It is expected to continue growing at a CAGR of 7.04%, reaching USD 10.28 billion by 2030.

This sustained expansion highlights increasing demand for effective management solutions and ongoing innovation in both pharmacologic and surgical interventions. Stakeholders must understand market dynamics and adapt to shifting regulatory and technological landscapes to seize emerging opportunities in this sector.

Scope & Segmentation of the Emphysema Treatment Market

For actionable insight and strategic planning, this report covers comprehensive categories across the emphysema treatment sector:

  • Treatment Types: Pharmacological (antibiotics, bronchodilators, corticosteroids, mucolytics) and surgical approaches (bullectomy, lung transplantation, lung volume reduction surgery, valve therapy).
  • Drug Classes: Anticholinergics, beta-agonists, combination drugs.
  • Therapy Lines: Adjunctive, first-line, maintenance (combination therapy, long-acting agents), and rescue therapies (short-acting agents).
  • Routes of Administration: Inhalation (dry powder inhalers, metered dose inhalers, nebulizers, soft mist inhalers), intravenous (infusion, injection), and oral (capsules, solutions, tablets).
  • Dosage Forms: Capsule, inhaler, nebulizer, solution, tablet.
  • Distribution Channels: Hospital pharmacy, online pharmacy, retail pharmacy.
  • Product Types: Brand and generic formulations.
  • Regional Coverage: Americas (with key U.S. states and Latin American countries), Europe, Middle East & Africa (spanning over 20 countries), and Asia-Pacific (including major and emerging economies across East, Southeast, and South Asia).
  • Company Landscape: Profiling GlaxoSmithKline plc, Boehringer Ingelheim, AstraZeneca, Novartis AG, Teva Pharmaceutical, Viatris, Chiesi Farmaceutici, Sunovion, Sandoz, and Cipla Limited.

Segmentation enables tailored go-to-market strategies, supports competitive differentiation, and identifies localized growth pockets for investment and resource optimization.

Key Takeaways for Senior Decision-Makers

  • Technological advances are redefining therapy delivery and patient adherence, with precision medicine and digital health integration at the forefront.
  • Innovative inhalation devices and the rise of minimally invasive surgical treatments address efficacy and recovery concerns while improving patient outcomes across geographies.
  • Tariff-driven supply chain realignments in major markets like the United States influence procurement, manufacturing strategies, and operational efficiency.
  • Regional disparities in infrastructure and reimbursement models necessitate locally adapted product and service portfolios to achieve market traction and improve access.
  • Strategic partnerships between global pharmaceutical leaders, device manufacturers, and biotechnology firms accelerate R&D and expand therapeutic pipelines.
  • The interplay between branded and generic drugs intensifies competition and drives the need for value-based contracting and tiered pricing strategies.

Tariff Impact: Navigating U.S. Regulatory Changes

Recent tariff modifications in the United States have increased import duties on key pharmaceutical products and device components used in emphysema therapeutics. Companies have responded by localizing manufacturing supply chains, forming new partnerships, and investing in material innovation to reduce costs and ensure supply continuity. These adaptations are crucial for maintaining price stability and reliable access, even as the market adjusts to evolving trade and regulatory conditions.

Methodology & Data Sources

The market insights in this report are grounded in a robust methodology, including qualitative interviews with pulmonologists, pharmaceutical executives, and device engineers. Quantitative surveys target hospital procurement leaders and patient groups, while findings are validated with secondary research from peer-reviewed journals, regulatory filings, and industry data. Thorough triangulation and quality control ensure an accurate and actionable analysis.

Why This Report Matters

  • Gain a strategic overview of crucial emphysema treatment market segments and emerging global trends to guide investment decisions.
  • Identify opportunities and risks related to technology, supply chain, and shifting regulatory landscapes in key regions.
  • Leverage data-driven recommendations to enhance competitive advantage, optimizing therapeutic offerings and market access strategies.

Conclusion

This report equips senior leaders with clear, actionable intelligence for navigating the evolving emphysema treatment market. By aligning with clinical, regulatory, and regional developments, organizations can drive sustained growth while improving patient outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Emergence of personalized inhalation devices with smart monitoring capabilities for emphysema patients
5.2. Adoption of regenerative stem cell therapies targeting alveolar tissue repair in emphysema management
5.3. Market adoption of next generation long acting bronchodilator combinations with enhanced safety profiles
5.4. Integration of cloud connected spirometry and digital health platforms for remote emphysema monitoring
5.5. Development of targeted anti inflammatory biologics to mitigate chronic alveolar degradation in emphysema
5.6. Collaborations between biotech startups and pulmonary research centers to expedite emphysema drug approvals
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Emphysema Treatment Market, by Treatment Type
8.1. Introduction
8.2. Pharmacological
8.2.1. Antibiotics
8.2.2. Bronchodilators
8.2.3. Corticosteroids
8.2.4. Mucolytics
8.3. Surgical
8.3.1. Bullectomy
8.3.2. Lung Transplantation
8.3.3. Lung Volume Reduction Surgery
8.3.4. Valve Therapy
9. Emphysema Treatment Market, by Drug Class
9.1. Introduction
9.2. Anticholinergics
9.3. Beta-Agonists
9.4. Combination Drugs
10. Emphysema Treatment Market, by Therapy Line
10.1. Introduction
10.2. Adjunctive
10.3. First-Line
10.4. Maintenance
10.4.1. Combination Therapy
10.4.2. Long-Acting Anticholinergics
10.4.3. Long-Acting Beta-Agonists
10.5. Rescue
10.5.1. Short-Acting Anticholinergics
10.5.2. Short-Acting Beta-Agonists
11. Emphysema Treatment Market, by Route Of Administration
11.1. Introduction
11.2. Inhalation
11.2.1. Dry Powder Inhaler
11.2.2. Metered Dose Inhaler
11.2.3. Nebulizer
11.2.4. Soft Mist Inhaler
11.3. Intravenous
11.3.1. Infusion
11.3.2. Injection
11.4. Oral
11.4.1. Capsule
11.4.2. Solution
11.4.3. Tablet
12. Emphysema Treatment Market, by Dosage Form
12.1. Introduction
12.2. Capsule
12.3. Inhaler
12.4. Nebulizer
12.5. Solution
12.6. Tablet
13. Emphysema Treatment Market, by Distribution Channel
13.1. Introduction
13.2. Hospital Pharmacy
13.3. Online Pharmacy
13.4. Retail Pharmacy
14. Emphysema Treatment Market, by Product Type
14.1. Introduction
14.2. Brand
14.3. Generic
15. Americas Emphysema Treatment Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Emphysema Treatment Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Emphysema Treatment Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. GlaxoSmithKline plc
18.3.2. Boehringer Ingelheim International GmbH
18.3.3. AstraZeneca plc
18.3.4. Novartis AG
18.3.5. Teva Pharmaceutical Industries Ltd
18.3.6. Viatris Inc.
18.3.7. Chiesi Farmaceutici S.p.A.
18.3.8. Sunovion Pharmaceuticals Inc.
18.3.9. Sandoz International GmbH
18.3.10. Cipla Limited
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. EMPHYSEMA TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 14. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. EMPHYSEMA TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. EMPHYSEMA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 29. EMPHYSEMA TREATMENT MARKET: RESEARCHAI
FIGURE 30. EMPHYSEMA TREATMENT MARKET: RESEARCHSTATISTICS
FIGURE 31. EMPHYSEMA TREATMENT MARKET: RESEARCHCONTACTS
FIGURE 32. EMPHYSEMA TREATMENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. EMPHYSEMA TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY BRONCHODILATORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY BRONCHODILATORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY MUCOLYTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY MUCOLYTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY BULLECTOMY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY BULLECTOMY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY LUNG TRANSPLANTATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY LUNG TRANSPLANTATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY LUNG VOLUME REDUCTION SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY LUNG VOLUME REDUCTION SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY VALVE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY VALVE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ANTICHOLINERGICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ANTICHOLINERGICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY BETA-AGONISTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY BETA-AGONISTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY COMBINATION DRUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY COMBINATION DRUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ADJUNCTIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ADJUNCTIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY FIRST-LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY FIRST-LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY LONG-ACTING ANTICHOLINERGICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY LONG-ACTING ANTICHOLINERGICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY LONG-ACTING BETA-AGONISTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY LONG-ACTING BETA-AGONISTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY SHORT-ACTING ANTICHOLINERGICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY SHORT-ACTING ANTICHOLINERGICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY SHORT-ACTING BETA-AGONISTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY SHORT-ACTING BETA-AGONISTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY METERED DOSE INHALER, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY METERED DOSE INHALER, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY NEBULIZER, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY NEBULIZER, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY SOFT MIST INHALER, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY SOFT MIST INHALER, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY INFUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY INFUSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY SOLUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY SOLUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY INHALER, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY INHALER, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY NEBULIZER, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY NEBULIZER, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY SOLUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY SOLUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY BRAND, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY BRAND, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 185. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 186. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 187. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 188. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 189. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 190. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 191. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 192. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 193. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2024 (USD MILLION)
TABLE 194. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2025-2030 (USD MILLION)
TABLE 195. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, 2018-2024 (USD MILLION)
TABLE 196. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, 2025-2030 (USD MILLION)
TABLE 197. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, 2018-2024 (USD MILLION)
TABLE 198. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, 2025-2030 (USD MILLION)
TABLE 199. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 200. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 201. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 202. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 203. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 204. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 205. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 206. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 207. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 208. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 209. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 212. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 213. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 214. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 215. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 216. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 217. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 218. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 219. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 220. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 221. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2024 (USD MILLION)
TABLE 222. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2025-2030 (USD MILLION)
TABLE 223. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, 2018-2024 (USD MILLION)
TABLE 224. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, 2025-2030 (USD MILLION)
TABLE 225. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, 2018-2024 (USD MILLION)
TABLE 226. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, 2025-2030 (USD MILLION)
TABLE 227. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 228. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 229. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 230. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 231. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 232. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 233. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 234. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 235. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 236. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 237. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 238. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 239. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 240. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 241. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 242. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 243. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 244. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 245. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 246. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 247. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 248. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 249. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2024 (USD MILLION)
TABLE 250. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2025-2030 (USD MILLION)
TABLE 251. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, 2018-2024 (USD MILLION)
TABLE 252. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, 2025-2030 (USD MILLION)
TABLE 253. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, 2018-2024 (USD MILLION)
TABLE 254. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, 2025-2030 (USD MILLION)
TABLE 255. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 256. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 263. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 264. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 267. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 268. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 269. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 270. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 271. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 272. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 273. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 274. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 275. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 276. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 277. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2024 (USD MILLION)
TABLE 278. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2025-2030 (USD MILLION)
TABLE 279. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, 2018-2024 (USD MILLION)
TABLE 280. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, 2025-2030 (USD MILLION)
TABLE 281. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, 2018-2024 (USD MILLION)
TABLE 282. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, 2025-2030 (USD MILLION)
TABLE 283. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 284. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 285. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 286. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 287. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 288. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 289. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 290. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 291. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 292. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 293. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 294. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 295. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 296. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 299. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 300. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 301. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 302. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 303. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 304. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 305. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2024 (USD MILLION)
TABLE 306. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2025-2030 (USD MILLION)
TABLE 307. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, 2018-2024 (USD MILLION)
TABLE 308. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, 2025-2030 (USD MILLION)
TABLE 309. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, 2018-2024 (USD MILLION)
TABLE 310. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, 2025-2030 (USD MILLION)
TABLE 311. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 312. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 313. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 314. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 315. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 316. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 317. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 318. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 319. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 320. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 321. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 322. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 323. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 324. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 325. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 326. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 327. UNITED KINGDOM EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 328. UNITED KINGDOM EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 329. UNITED KINGDOM EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 330. UNITED KINGDOM EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 331. UNITED KINGDOM EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 332. UNITED KINGDOM EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 333. UNITED KINGDOM EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 334. UNITED KINGDOM EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 335. UNITED KINGDOM EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2024 (USD MILLION)
TABLE 336. UNITED KINGDOM EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Emphysema Treatment market report include:
  • GlaxoSmithKline plc
  • Boehringer Ingelheim International GmbH
  • AstraZeneca plc
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd
  • Viatris Inc.
  • Chiesi Farmaceutici S.p.A.
  • Sunovion Pharmaceuticals Inc.
  • Sandoz International GmbH
  • Cipla Limited

Table Information

Report AttributeDetails
No. of Pages186
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 7.32 Billion
Forecasted Market Value ( USD ) by 2030 $ 10.28 Billion
Compound Annual Growth Rate7.0%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Emphysema Treatment Market Report 2025 - Product Image

Emphysema Treatment Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Emphysema Treatment Market Size Analysis Report - Market Share, Forecast Trends and Outlook (2025-2034) - Product Image

Emphysema Treatment Market Size Analysis Report - Market Share, Forecast Trends and Outlook (2025-2034)

  • Report
  • 400 Pages
  • Global
From
Emphysema Treatment Medication Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Emphysema Treatment Medication Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Emphysema - Pipeline Insight, 2025 - Product Image

Emphysema - Pipeline Insight, 2025

  • Clinical Trials
  • 80 Pages
  • Global
From
Emphysema Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Emphysema Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From

About the Emphysema Drug Market

The Emphysema Drug market is a subset of the larger Respiratory Drugs market. It is composed of drugs used to treat emphysema, a chronic lung disease that causes shortness of breath, coughing, and wheezing. These drugs are typically inhaled corticosteroids, bronchodilators, and phosphodiesterase-4 inhibitors. They are used to reduce inflammation, open airways, and improve breathing. The Emphysema Drug market is highly competitive, with many companies offering similar products. Some of the major players in the market include GlaxoSmithKline, AstraZeneca, Novartis, Merck, and Boehringer Ingelheim. Other companies, such as Sunovion, Teva Pharmaceuticals, and Mylan, also offer products in this market. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.